# PET/MRI in Rectal Cancer

> **NCT06057831** · PHASE2 · NOT_YET_RECRUITING · sponsor: **AHS Cancer Control Alberta** · enrollment: 40 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **RADIATION:** Total Neo-adjuvant Therapy
- **OTHER:** 18FDG-PET/MRI scan

## Key facts

- **NCT ID:** NCT06057831
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2029-05
- **Final completion:** 2030-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06057831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06057831, "PET/MRI in Rectal Cancer". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT06057831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*